incretin mimetic agents glp 1 receptor agonists GLP1 Agonists—Effects beyond Obesity and Diabetes Frontiers | Mechanisms of action

These reserve cells, which typically do not immediately differentiate or amalgamate into myotubes, were apparently at a reduced proportion in the culture

Additionally, by improving insulin sensitivity and blood sugar regulation, GLP-1 medications help address the metabolic changes that may contribute to abdominal weight gain

Circadian etiology of type 2 diabetes mellitus

It has potential in treatment of type 2 diabetes and obesity, usually in combination with semaglutide (like CargiSema)

It is the only peptide in this group that is currently FDA-approved specifically for the reduction of excess abdominal fat in HIV patients with lipodystrophy